ProKidney (PROK) Stock Price, Quote, News & History | Benzinga

SPY777.02−0.27%QQQ757.26−0.32%BTC/USD83,300.97−2.63%DIA511.04−0.68%GLD376.33−1.55%TLT77.15−0.17%

ProKidney Corp (PROK) Stock Price, Quote, News & History

PROKNASDAQ

Trade with Public

Trade with Public

$1.57

-0.03-1.88%

Last update: Oct 7, 3:37 PM

$1.60

N/A

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.56

Close

-

Volume / Avg.

532.53K / 1.30M

Day Range

$1.56 - $1.60

52 Wk Range

1.30 - 3.48

Market Cap

$328.02M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

13.8%

Days to Cover

19.04

Recent Prokidney Corp News

AEVEX, Abivax, Watts Water Technologies And Other Big Stocks Moving Higher On Tuesday

Stocks up, Dow Jones +100 points. AEVEX Corp shares rose 11.8% on $50m Air Force contract. Other big gainers: ABVX +34.2%, ESBA +20.9%, AVAV +20.4%, AIRJ +17.4%, FCEL +14%, UMAC +11.1%, HSAI +10.7%, PROK +9.3%, WOLF +9.1%, APD +8.6%

Avi Kapoor

Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Biohaven (BHVN) shares down after BofA downgrade and enrollment of first patient in phase 3 trial.

Avi Kapoor

This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Avi Kapoor

SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC

Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.

Chris Katje

Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%

Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the poor performance track record.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-141.17M

Investing Cash Flow (TTM)

104.74M

Financing Cash Flow (TTM)

26.35M

Free Cash Flow (TTM)

-159.73M

Capital Expenditure (TTM)

-18.57M

Net Change in Cash (TTM)

-10.07M

Analyst Trends and Forecast

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.9

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$153.11M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

292.97

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-34.70%

Earnings Yield % (FWD)

-35.33%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$4.23

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$8.00K

Total Cash

$74.87M

Debt to Equity

-

Issuance of Debt (TTM)

-$8.00K

Repayment of Debt (TTM)

-$8.00K